Heat-shock proteins (HSP) 90 exert a relevant role in the survival and response to therapy of many neoplastic cell types. Here, we show that the promoter of hsp90a gene, that encodes the inducible form of HSP90, is regulated by nuclear factor-jB (NF-jB) activity. Indeed, we found that NF-jB factors bound to one of the two putative consensus sequences present in the hsp90a-flanking region; mutation of such motif hampered the phorbol-myristate-13-acetatestimulated expression of a luciferase reporter gene under the control of the hsp90a promoter. Furthermore, the downmodulation of NF-jB (p65) levels by a specific small interfering (si) RNA resulted in reducing the levels of endogenous HSP90a protein. These findings disclose a previously unrecognized mechanism that contributes to connect NF-jB factors and HSPs in cell defence machinery.
The heat-shock protein (HSP) 90 belongs to the class of molecular chaperones that participate in the normal folding, intracellular localization and proteolytic turnover of several proteins, including key regulators of cell growth and survival (Pearl and Prodromou, 2003; Richter et al., 2007) . Two major cytoplasmic forms, a (inducible) and b (constitutive), of the protein are recognized; a third isoform, HSP90N, appears to derive from a very recent gene rearrangement of hsp90a, while two HSP90 analogues, Grp94 and HSP75/TRAP1, are located in the mitochondrial matrix (Young et al., 2004) . Owing to its inducible expression, HSP90a exerts a relevant role in cell homeostatic responses to stressful conditions. In neoplastic cells, this chaperone is implicated in cell protection against proapoptotic stimuli, originating from de-regulated proliferation or chemotherapeutic agents (Whitesell and Lindquist, 2005) .
Among proteins that participate in antiapoptotic pathways, there are nuclear factor-kB (NF-kB) transcription factors (Maiuri et al., 2004; Karin and Greten, 2005) . Two NF-kB putative consensus sequences (seq. 1 and 2) are present in the hsp90a (and not in the hsp90b) flanking region ( Figure 1A ). Nuclear extracts from tumor necrosis factor (TNF)-a-stimulated HeLa cells bound selectively to seq. 1 in electrophoretic mobility shift assays (EMSA) ( Figure 1B ). To confirm the interaction of NF-kB factors with seq. 1, we stimulated HeLa cells with 10 ng/ml TNF-a for 2 or 4 h and used an anti-p65 antibody for chromatin immunoprecipitation (ChIP) (Tanaka and Nasmyth, 1998) ; rabbit IgGs were used as a negative control. p65 binding to Hsp90 akB seq. 1 was evident in immunoprecipitates from 2 to 4 h stimulated cells ( Figure 1C ) Promoter sequences from nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor alpha (IkBa) and b-actin were used as positive and negative controls, respectively.
To investigate the activation of the hsp90a promoter by NF-kB factors, we performed site-directed mutagenesis of either seq. 1 or 2 in a construct (HspLuc1430) carrying a luciferase reporter gene driven by the hsp90a promoter and analysed luciferase levels in HEK-293-transfected cells. As shown in Figure 2 , cells transfected with the wild type (HspLuc1430) or mutated (HspLuc1430 no. 1; HspLuc1430 no. 2) constructs displayed similar basal levels of luciferase activity. When the cells were incubated with the NF-kB activating agent phorbolmyristate-13-acetate (PMA), we detected increased levels of luciferase activity in cells transfected with either HspLuc1430 or HspLuc1430 no. 2, but not in cells transfected with HspLuc1430 no. 1 (Figure 2 ). These experiments confirmed that seq. 1 regulated the activity of the hsp90a promoter.
We then verified whether NF-kB activity influenced HSP90a protein levels. First, we analysed the time-and dose-dependent effect of TNF-a on HSP90a amounts: HSP90a increase was particularly evident after 4 h of cell incubation with the cytokine (Figure 3a ) and using a TNF-a concentration of 10 ng/ml ( Figure 3b ). We then transfected the cells with a small interfering (siRNA) specific for p65 or, for comparison, with a heat shock protein (HSF)1-specific siRNA, since several HSP-1-responsive elements (HSE) are present in the hsp90a promoter (NCBI GenBank U25822gi|793941| gb|U25822.1|HSU25822, TESS) and regulate its acti- (Romano et al., 1999) for their binding to 32 P-labelled-kB oligonucleotides, corresponding to sequences 1 (5 0 -AGCGGAGG TAGTTCCATCGTTT-3 0 and 5 0 -TCGCCTCCATCAAGGTAGCAAA-3 0 ) or 2 (5 0 -ATATCCGAAAATTCCCATGTAG-3 0 and 5 0 -TATAGGCTTTTAAGGGTACATC-3 0 ), in EMSA. (b) Nuclear extracts from TNF-a-stimulated cells were incubated with 50-fold concentrated specific or non-specific (Oct-1 consensus) cold competitors, or with antibodies recognizing NF-kB subunits (anti-c-Rel, -p50 or -p65 polyclonal antibodies, Santa Cruz Biotechnology, Santa Cruz, CA, USA). Protein-oligo complexes were analysed by EMSA. Supershifted complexes are indicated by the arrows. (C) HeLa cells were stimulated with 10 ng/ml TNF-a for 60 and 120 min. ChIP assay was performed according to the manufacturer's (Upstate Cell Signaling Solutions, Charlottesville, VA, USA) instruction. Briefly, HeLa cells were collected at the indicated times and nuclear extracts were obtained using NE-PER Kit (Pierce, Rockford, IL, USA). Chromatin from HeLa cells was formaldehyde crosslinked, shared by sonication (four times, 15 s each, one-third power) and immunoprecipitated with p65 antibody (anti-p65 polyclonal antibody C-20, Santa Cruz Biotechnology) followed by incubation with protein A-Sepharose saturated with salmon sperm DNA. IgGs from a rabbit serum (DAKO A/S, Glostrup, Denmark) were used as negative control. After reversal of the crosslinking, the purified DNA fragments were subjected to PCR to amplify a segment spanning the kB seq. 1 on the Hsp90a promoter. Input DNA from fragmented chromatin before immunoprecipitation was used to monitor equal starting conditions. Primers used in PCR were: hsp90a kB seq. 1, FWD: 5 0 -CCAGGCAAGACGCTTTATGT-3 0 and REV: 5 0 -CTCCAGCCAGACTCATAGCC-3 0 ; IkBa promoter (À316 to À15), FWD 5 0 -GACGACCCCAATTCAAATCG-3 0 and REV 5 0 -TCAGGCTCGGGGAATTTCC-3 0 ; b-actin promoter (À980 to -915), FWD 5 0 -TGCACTGTGCGGCGAAGC-3 0 and 5 0 -TCGAGC CATAAAAGGCAA-3 0 . IkBa promoter primers were designed to amplify the kB responsive elements as positive control. b-Actin promoter primers were used as negative control. The products were analysed on 1.5% (w/v) agarose gels and stained with ethidium bromide. The graph depicts the values obtained by PCR bands using densitometry. Bands obtained by immunoprecipitation with antip65 antibody were normalized against DNA input; the baseline (T 0 ) derived from untreated cells was set at 100. ChIP, chromatin immunoprecipitation; EMSA, electrophoretic mobility shift assay; NF-kB, nuclear factor-kB; TNF-a, tumor necrosis factor.
Regulation of hsp90a promoter by NF-jB activity M Ammirante et al vity (Morimoto et al., 1992) . Transfected cells were incubated with 10 ng/ml TNF-a for 4 h and total lysates were analysed by western blotting. Downmodulation of p65 levels resulted in reducing HSP90a levels by >50%. A number of evidence indicated that HSP90a is required for inhibitor of kappa light polypeptide gene 0 -flanking region of the human hsp90a gene promoter (HSPLuc1430) and promoterless vector (pXP2) for luciferase assays were kindly provided by Professor KJ Wu, IBMB, National Yang-Ming University, Taiwan. NF-kB-luciferase reporter construct (NF-kB-luc) containing five kB elements was a gift from Dr Andrew Bowie, Department of Biochemistry and National Pharmaceutical Biotechnology Centre, Trinity College, Dublin 2, Ireland. Site-directed mutagenesis of the hsp90a promoter inserted in HspLuc1430 was performed by PCR using the QuikChange Site-directed Mutagenesis Kit (Stratagene, La Jolla, CA, USA) according to the manufacturer's directions. The mutagenic primers used for generating HspLuc1430 no. 1 and HspLuc1430 no. 2 mutants were respectively: sense 5 0 -GGA AGCGGAGGTACTTCCATCGTTTCT-3 0 , antisense 5 0 -AGAA ACGATGGAAGTACCTCCGCTTCC-3 0 ; and sense 5 0 -CCAAG ATATCCGAAAGTTCCCATGTAGAAAC-3 0 , antisense 5 0 -GT TTCTACATGGGAACTTTCGGATATCTTGG-3 0 . PCR was performed using PfuTurbo DNA polymerase, HspLuc1430 as template and the proper mutagenic primers. PCR products were digested with DpnI endonuclease and vectors DNA containing the desired mutations were then transformed into XL1-Blue supercompetent cells. The presence of the correct mutated sequence and the absence of PCR-derived alterations in the promoter sequence were confirmed by completely sequencing both strands of each construct. The mutations chosen generated sequences without homology to kB-binding sites, as assessed by a search made in TESS (Transcription Element Search System, UPENN, Philadelphia, PA, USA, http://www.cbil.upenn.edu/ cgibin/tess/tess database). HEK-293 cells (ATCC) (5 Â 10 6 ) were transiently transfected with luciferase reporter gene under the control of the hsp90a gene promoter region, either wild type (HspLuc1430) or mutated in the NF-kB consensus seq. 1 (HspLuc1430 no. 1) or 2 (HspLuc1430 no. 2), using FuGene 6 transfection reagents (Roche). Cells were stimulated with the NF-kB inducer PMA (Sigma Chemical Co., St Louis, MO, USA) (10 ng/ml) and after 48 h luciferase activity was assayed using the Dual-GloTM Luciferase Assay System (Madison, WI, USA), according to the manufacturer's instruction, and a Perkin Elmer luminometer (Boston, MA, USA). NF-kB, nuclear factor-kB. (Broemer et al., 2004) and for constitutive and inducible IKK and NF-kB activation (Chen et al., 2002; Field et al., 2003; Broemer et al., 2004; Pittet et al., 2005; Mitsiades et al., 2006) . Our results demonstrate that, in turn, NF-kB activity can influence hsp90a expression. The reciprocal interactions of HSP90a and NF-kB activities are likely to constitute a regulatory loop, able to influence cell survival and response to stressful agents.
